李奇华坦的Hooxue配方可通过NRG-1/PI3K/AKT通路缓解冠状动脉微血管功能障碍
概括
传统中医药配方LQHTHX在治疗冠状动脉微血管功能障碍 (CMD) 方面表现有前途. 它减少了老鼠的心脏损伤,并在实验室测试中改善了细胞功能,可能是通过NRG-1/PI3K/AKT途径.
科学领域:
- 心血管研究研究心血管研究
- 药理学 药理学是指药理学的学科.
- 传统中国医药 传统中国医药
背景情况:
- 冠状动脉微血管功能障碍 (CMD) 显著影响患者的生活质量.
- 传统中医 (TCM) 为CMD管理提供了潜在的治疗途径.
研究的目的:
- 分析Liqi Huatan Huoxue (LQHTHX) 配方的化学特征和吸收成分.
- 使用体内和体外模型评估LQHTHX对CMD的治疗效果.
主要方法:
- 液态染色体质谱法 (LC-MS) 确定了LQHTHX的化学成分和被吸收的成分.
- 劳拉特诱导的CMD大鼠模型和缺氧诱导的心脏微血管内皮细胞 (CMEC) 模型用于疗效评估.
主要成果:
- 诺比丁,科里达林和异素素被确定为LQHTHX的血液吸收成分.
- 在CMD大鼠心脏组织中,LQHTHX治疗减少了原沉积,炎症和亡.
- LQHTHX改善了CMEC活力,增殖,线粒体功能,迁移,并减少了亡,可能是通过NRG-1和PI3K/AKT通路激活.
结论:
- LQHTHX显示出对CMD的显著治疗潜力.
- 这项研究为开发基于天然产品的CMD干预措施提供了基础.
相关概念视频
01:28Nitric Oxide Signaling Pathway
6.1K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.1K
01:22PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K